6WR1
Human steroidogenic cytochrome P450 17A1 mutant N52Y with inhibitor abiraterone
Summary for 6WR1
| Entry DOI | 10.2210/pdb6wr1/pdb |
| Descriptor | Steroid 17-alpha-hydroxylase/17,20 lyase, PROTOPORPHYRIN IX CONTAINING FE, Abiraterone, ... (4 entities in total) |
| Functional Keywords | cytochrome p450, p450, 17a1, oxidoreductase |
| Biological source | Homo sapiens (Human) |
| Total number of polymer chains | 2 |
| Total formula weight | 113510.41 |
| Authors | Petrunak, E.M.,Bart, A.G.,Scott, E.E. (deposition date: 2020-04-29, release date: 2021-05-05, Last modification date: 2024-04-03) |
| Primary citation | Petrunak, E.M.,Bart, A.G.,Peng, H.M.,Auchus, R.J.,Scott, E.E. Human cytochrome P450 17A1 structures with metabolites of prostate cancer drug abiraterone reveal substrate-binding plasticity and a second binding site. J.Biol.Chem., 299:102999-102999, 2023 Cited by PubMed: 36773804DOI: 10.1016/j.jbc.2023.102999 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.85 Å) |
Structure validation
Download full validation report
